Maltodextrin
- Generic Name
- Maltodextrin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9050-36-6
- Unique Ingredient Identifier
- 7CVR7L4A2D
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT06444763
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia
Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT06440252
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT06436781
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia
Effect of Maolactin on Gastrointestinal Tract (GIT) Health
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT06104917
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Anders Fink-Jensen, MD, DMSci
- Target Recruit Count
- 90
- Registration Number
- NCT05416229
- Locations
- 🇩🇰
Psychiatric Center Copenhagen, Frederiksberg Hospital, Frederiksberg, Denmark
Effect of a Synbiotic on Symptoms of Patients With STC
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-07-26
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Jinling Hospital, China
- Target Recruit Count
- 100
- Registration Number
- NCT02844426
- Locations
- 🇨🇳
Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University, Nanjing, Jiangsu, China
A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Prim. Prof. Dr. Oliver Findl, MBA
- Target Recruit Count
- 60
- Registration Number
- NCT02215330
- Locations
- 🇦🇹
Oliver Findl, Vienna, Austria
Study of Sc-FOS for Pouchitis Prevention
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 13
- Registration Number
- NCT02203955
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
GOS Prebiotic Effect in Children Constipation
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- University of Campinas, Brazil
- Target Recruit Count
- 20
- Registration Number
- NCT02183766
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2020-09-11
- Target Recruit Count
- 69
- Registration Number
- NCT02127125
- Locations
- 🇺🇸
Audie L. Murphy VA Hospital, STVHCS, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath